NCT00571298
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Clinical trial condition
Malignant Pleural Mesothelioma
Explore clinical trials studying Malignant Pleural Mesothelioma. Study availability and eligibility vary by location and protocol.
60 public trials
6 recruiting studies
Malignant Pleural Mesothelioma trial results
NCT01212367
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01024946
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00867711
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Istituto Clinico Humanitas Rozzano, Milano, Italy
NCT00165555
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +13 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00165516
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +13 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01243632
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Institute of Oncology Ljubljana Ljubljana, Slovenia
NCT00280982
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Department of Pulmonary Medicine Rotterdam, South Holland, Netherlands
NCT00272558
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Dept. Oncol., Rigshospitalet Copenhagen, Denmark
NCT00386815
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyōgo, Japan